Boill Healthcare Holdings Limited
HKEX:1246.HK
0.021 (HKD) • At close July 24, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 285.204 | 348.271 | 1,004.596 | 216.71 | 106.352 | 419.762 | 738.147 | 487.119 | 532.194 | 558.15 | 486.906 | 356.1 |
| Cost of Revenue
| 274.684 | 349.081 | 897.748 | 197.739 | 95.563 | 430.208 | 846.758 | 676.104 | 480.404 | 408.371 | 353.509 | 248.827 |
| Gross Profit
| 10.52 | -0.81 | 106.848 | 18.971 | 10.789 | -10.446 | -108.611 | -188.985 | 51.79 | 149.779 | 133.397 | 107.273 |
| Gross Profit Ratio
| 0.037 | -0.002 | 0.106 | 0.088 | 0.101 | -0.025 | -0.147 | -0.388 | 0.097 | 0.268 | 0.274 | 0.301 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 40.571 | 21.687 | 32.173 | 67.874 | 49.912 | 80.006 | 106.348 | 81.616 | 84.839 | 60.189 | 47.293 | 7.918 |
| Selling & Marketing Expenses
| 6.971 | 7.747 | 14.634 | 15.693 | 7.068 | 12.718 | 22.063 | 7.141 | 2.251 | 0.966 | 0 | 0 |
| SG&A
| 47.542 | 26.182 | 36.056 | 71.447 | 55.011 | 92.724 | 128.411 | 88.757 | 87.09 | 61.155 | 47.293 | 7.918 |
| Other Expenses
| -36.613 | -159.597 | -0.004 | -0.161 | 0.054 | 2.352 | -22.557 | -194.172 | -102.781 | 2.454 | 0.054 | 17.958 |
| Operating Expenses
| 47.542 | 185.779 | 36.06 | 71.447 | 54.957 | 137.662 | 43.979 | 275.561 | 182.124 | 42.065 | 42.221 | 25.876 |
| Operating Income
| -37.022 | -186.589 | 70.788 | -52.476 | -44.168 | -103.17 | -237.022 | -277.742 | -35.3 | 88.624 | 86.326 | 75.819 |
| Operating Income Ratio
| -0.13 | -0.536 | 0.07 | -0.242 | -0.415 | -0.246 | -0.321 | -0.57 | -0.066 | 0.159 | 0.177 | 0.213 |
| Total Other Income Expenses Net
| -238.48 | -38.047 | -55.458 | -127.213 | -155.152 | -122.683 | 5.758 | -314.115 | -164.881 | 18.072 | 3.697 | -6.015 |
| Income Before Tax
| -275.502 | -224.636 | 15.33 | -179.689 | -199.32 | -225.853 | -231.264 | -591.857 | -200.181 | 106.696 | 90.023 | 75.382 |
| Income Before Tax Ratio
| -0.966 | -0.645 | 0.015 | -0.829 | -1.874 | -0.538 | -0.313 | -1.215 | -0.376 | 0.191 | 0.185 | 0.212 |
| Income Tax Expense
| 7.625 | 1.998 | 8.947 | -5.139 | 20.875 | 1.986 | 9.208 | 18.559 | 6.788 | 16.134 | 16.644 | 12.963 |
| Net Income
| -118.64 | -428.255 | -517.798 | -142.486 | -189.432 | -200.114 | -214.164 | -570.475 | -193.393 | 90.562 | 73.379 | 62.419 |
| Net Income Ratio
| -0.416 | -1.23 | -0.515 | -0.657 | -1.781 | -0.477 | -0.29 | -1.171 | -0.363 | 0.162 | 0.151 | 0.175 |
| EPS
| -0.087 | -0.32 | -0.38 | -0.13 | -0.21 | -0.22 | -0.24 | -1.18 | -1.87 | 1.09 | 1.04 | 1.04 |
| EPS Diluted
| -0.087 | -0.32 | -0.38 | -0.13 | -0.21 | -0.22 | -0.24 | -1.18 | -1.87 | 1.09 | 1.04 | 1.04 |
| EBITDA
| -36.805 | -185.64 | 73.455 | -32.738 | -34.219 | -91.358 | -209.829 | -244.829 | -5.932 | 109.513 | 100.613 | 93.873 |
| EBITDA Ratio
| -0.129 | -0.533 | 0.073 | -0.151 | -0.322 | -0.218 | -0.284 | -0.503 | -0.011 | 0.196 | 0.207 | 0.264 |